Fresenius Medical Care
(NYSE) FMS
Fresenius Medical Care Financials at a Glance
Market Cap
$11.99B
Revenue (TTM)
$19.36B
Net Income (TTM)
$944.60M
EPS (TTM)
$1.90
P/E Ratio
11.68
Dividend
$0.81
Beta (Volatility)
0.48 (Low)
Dividend
$0.81
Beta (Volatility)
0.48 (Low)
Price
$22.40
Volume
274,462.004
Open
$22.23
Price
$22.40
Volume
274,462.004
Open
$22.23
Previous Close
$22.20
Daily Range
$22.23 - $22.48
52-Week Range
$20.02 - $29.71
Dividend
$0.81
Beta (Volatility)
0.48 (Low)
Price
$22.40
Volume
274,462.004
Open
$22.23
Previous Close
$22.20
Daily Range
$22.23 - $22.48
52-Week Range
$20.02 - $29.71
FMS News
FMS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Fresenius Medical Care
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
108,165
CEO
Helen Giza, MBA
Headquarters
Bad Homburg, 61352, DE
FMS Financials
Key Financial Metrics (TTM)
Gross Margin
26%
Operating Margin
10%
Net Income Margin
5%
Return on Equity
7%
Return on Capital
8%
Return on Assets
3%
Earnings Yield
8.56%
Dividend Yield
3.67%
Payout Ratio
44.71%
Stock Overview
Market Cap
$11.99B
Shares Outstanding
540.18M
Volume
274.46K
Avg. Volume
663.34K
Financials (TTM)
Gross Profit
$5.03B
Operating Income
$1.83B
EBITDA
$2.96B
Operating Cash Flow
$2.58B
Capital Expenditure
$879.24M
Free Cash Flow
$1.70B
Cash & ST Invst.
$1.60B
Total Debt
$10.79B
Fresenius Medical Care Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$4.61B
-5.5%
Gross Profit
$1.18B
-0.4%
Gross Margin
25.57%
N/A
Market Cap
$11.99B
N/A
Market Cap/Employee
$107.04K
N/A
Employees
112,035
N/A
Net Income
$117.53M
-22.3%
EBITDA
$763.76M
+3.1%
Quarterly Fundamentals
Net Cash
$9.41B
+3.7%
Accounts Receivable
$3.72B
+3.4%
Inventory
$2.30B
+10.8%
Long Term Debt
$8.64B
-9.1%
Short Term Debt
$2.39B
+81.9%
Return on Assets
3.00%
N/A
Return on Invested Capital
7.96%
N/A
Free Cash Flow
$36.82M
+115.8%
Operating Cash Flow
$226.89M
+39.3%